Not surprisingly, affordability is a bigger problem for uninsured people.

In a recent study, 40% of traditionally employed professionals said they are thinking about switching to self-employment,

It argued the ICER study did not consider the full range of clinical data on the drugs it assesses, and that its analyses lack context.

Still, labor market volatility is causing employers to put a new emphasis on benefits, creating an opportunity for brokers.

Unsupported drug price increases have cost the U.S. health system $1.67 billion.

Even states that are generally considered high-performers in terms of overall health could see wide disparities.

Companies are seeing significant growth in demand for benefits beyond the traditional forms such as health insurance.

The top costs include $6.6 billion in productivity losses, $895 million associated with cesarean section deliveries, $350 million for increased hospital stays.